IMEMR
66.92
Volume 5, Issue 4 (2024)                   J Clinic Care Skill 2024, 5(4): 181-187 | Back to browse issues page
Article Type:
Original Research
Subject:

Print XML PDF

Ethics code: IR.YUMS.REC.1402.120


History

How to cite this article
Mostafavi L, Bagheri Fard A, Rahami Z. Effect of Ginseng on the Sexual Dysfunction in Patients with Diabetes. J Clinic Care Skill 2024; 5 (4) :181-187
URL: http://jccs.yums.ac.ir/article-1-295-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
1- Department of Psychiatry, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
2- Clinical Research Development Unit Shahid Jalili Hospital, Yasuj University of Medical Sciences, Yasuj, Iran
3- Department of Internal Medicine, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
* Corresponding Author Address: Yasuj University of Medical Sciences, Shahid Motahari Boulevard, Yasuj, Boyer-Ahmad, Iran. Postal Code: 75914-93686 (z.rahami.65@gmail.com)
Full-Text (HTML)   (27 Views)
Introduction
Diabetes is the endocrine disease in the world and leads to about 4 million deaths per year [1]. It is stated the global prevalence of diabetes is about 552 million people by 2030 [2]. Also, it is estimated that the annual growth rate of diabetes in Iran will reach second place in the region after Pakistan by 2030 [3]. Diabetes is chronic diseases that affect different organs and systems of the body [4]. Diabetes can lead to a variety of sexual disorders and complications that affect both men and women. In men, diabetes is a significant risk factor for erectile dysfunction (ED), which is characterized by the inability to achieve or maintain an erection sufficient for sexual intercourse. ED is one of the common complications of diabetes, the prevalence of which is approximately 3.5 times higher in men with diabetes than in men without diabetes. The development of ED in men with diabetes is often related to the severity and duration of diabetes, as well as the presence of comorbidities such as hypogonadism, metabolic syndrome, obstructive sleep apnea, and depression [5]. Diabetes in women can also cause significant sexual dysfunction. Studies have shown that women with type 1 diabetes have more sexual dysfunction compared to their age-matched counterparts. The prevalence of female sexual dysfunction (FSD) in women with type 2 diabetes is even higher, with a study in Iran reporting that 78.7% of women with type 2 diabetes have experienced some form of sexual dysfunction. Common sexual problems in women with diabetes include loss of orgasm disorder, libido, pain, and arousal disorder during intercourse [6, 7].
Herbal medicines are an important natural resource for drug development. Various pathological conditions can be treated with medicines derived from plants. A number of modern medicines originate from traditional medicines [8]. Several studies show that ginseng attenuates cardiovascular diseases [9], inflammatory bowel disease [10], Alzheimer's disease [11], and type 2 diabetes mellitus [12-15]. Ginseng is a complex substance including bioactive and potentially effective therapeutic compounds [16, 17]. Ginsenoside is the main component of ginseng that has anti-cancer effects [18]. In recent years, the use of herbal medicines in the treatment of erectile dysfunction has also attracted much attention. Several studies have reported the positive effects of onion in improving sexual performance. The use of onion as an aphrodisiac food to increase sexual desire and strengthen the reproductive organs has been emphasized a lot in traditional medicine [19]. Among the herbal medicines used in male sexual dysfunction are Ginkgo Biloba, Red Ginseng, and pollen (used in traditional Chinese medicine with the scientific name: Epimedium). Ginseng was marketed as a supplement capable of increasing potency, and sexual activity [20].
Ginseng has shown promising sexual benefits, especially in postmenopausal women and men with erectile dysfunction, as it contains ginsenoside compounds that enhance sexual performance by increasing the release of neurotransmitters. In postmenopausal women, ginseng significantly improved sexual function, quality of life, and reduced menopausal symptoms in a randomized controlled trial [21]. In men with erectile dysfunction, ginseng supplementation led to significant improvements in erectile function and overall satisfaction in various studies. These effects are believed to be due to ginseng's ability to increase nitric oxide production and modulate neural pathways involved in sexual function. While ginseng is generally safe, it can interact with medications and may cause mild side effects, emphasizing the importance of consulting a healthcare professional before use [22]. In the study by De Andrade et al., the results indicated the therapeutic effectiveness of ginseng in men with erectile dysfunction [23].
Ginseng has a long history of use in traditional medicine for various health benefits, including its purported aphrodisiac effects. However, its effectiveness in diabetic patients has not yet been investigated. Therefore, the aim of this study was to investigate the effect of soft gelatin capsules of ginseng on sexual desire in patients with diabetes.

Materials and Methods
Design
This double-blind clinical trial research was conducted at Yasuj University of Medical Sciences with IRCT20231129060218N2 from the Iranian Registry of Clinical Trials, on 80 patients with diabetes (type 1 and 2) referring to Shahid Mufteh Medical Clinic in Yasuj, Iran. It was done in 2024-02 until 2024-10.
Sampling and participants
Based on Chung et al.’s study [24], ginseng can increase the libido index in diabetic patients in the range of 3-10 and with a variance of 16, so the sample size, considering a type I error of 5%, a test power of 80%, the estimated variance of changes in libido in the intervention and control groups was 25 and 16, respectively. Taking into account the drop in the sample size, 40 patients were obtained in each group.
Inclusion criteria included heterosexual men and women aged 30 to 55 years with diabetes, at least 3 years had passed since diagnosis, were sexually active for at least 6 months, were sexually active during the 8 weeks of the study, and sexual dysfunction was confirmed by the relevant questionnaire. Exclusion criteria included non-cooperation in the treatment process, incomplete questionnaires and patient records, and intolerance or allergic reaction to ginseng.
80 patients with diabetes (type 1 and 2) were selected based on the convenience sampling method and randomized into two groups (40 patients in each group) including the intervention group (ginseng recipients) and a control group (placebo recipients) using sealed envelopes.
Intervention
Intervention group: In this study, the effect of 100-200 mg of ginseng capsules on the sexual performance of men and women with diabetes was investigated. Each ginseng capsule contained 100 mg of dry ginseng extract (provided by Dana company in Iran), and patients in the intervention group consumed one capsule (equivalent to 100 mg) daily in the first week. Then, if the samples tolerated the amount of 100 mg, they received two capsules (equivalent to 200 mg) daily. The intervention was continued for 8 weeks.
Control group: The placebo capsules looked exactly the same as the ginseng capsules.
The capsules were placed in exactly the same bottles with codes A and B. The selection of samples was done in a continuous manner and the samples were randomly divided into 2 intervention and control groups using sealed envelopes.
Blinding: The researcher and the patient remained unaware of their group until the end of the study.
Instrument and sampling
A blood sample was taken from the patients to test HBA1C, testosterone, prolactin, LDL, and HDL before giving the drug. The tests were performed using the calorimetric method and a Hitachi device (Japan). The International Erectile Function Scale (IIEF) and the Female Sexual Function Index (FSFI) were used to evaluate the effectiveness of the intervention (ginseng) in the men, and women, respectively.
International Erectile Function Scale (IIEF): The International Erectile Function Scale is a standard scale that was made by Rosen et al. [25]. It has 15 questions and measures 5 subscales of sexual function including sexual desire (cases 11, 12, and score 1-10), orgasmic function (cases 9-10, and score 0-10), intercourse satisfaction (cases 6-8 q, and score 0-15), erectile function (cases 1, 2, 3, 4.5, 15, and score 1-30) and overall satisfaction (cases 13, 14, and score 0-15). A 5-point Likert scale (1-5) was used to score the questions. A score of five was for normal functioning. A higher score indicated better sexual functioning and the maximum acceptable score was 75, which indicated the best sexual condition. In the Iranian version, the content validity index and ratio values were more than 0.78 and 0.90 respectively, and Cronbach’s coefficient was 0.80 for all dimensions [26].
Female Sexual Function Scale (FSFI): This scale was made by Rosen et al. [27]. It measures women's sexual function in 6 subscales, including desire (2 questions), arousal (4 questions), lubrication (4 questions), orgasm (3 questions), pain (3 questions), and sexual satisfaction (3 questions), with 19 questions. A higher score indicated better sexual functioning [28]. The scores for each question range from 0 to 5, with a score of 0 being considered as a non-sexual activity, and a score of 5 being equivalent to better performance in that area (except for the first and second questions, which are given scores of 1-5). Total scale scores are obtained by adding the six domain scores. The minimum score is 2 and the maximum score is 36. The Persian version of this instrument was made by Mohammadi et al. The reliability and validity of the scale were confirmed. Cronbach’s coefficient was 0.70 for all dimensions [29].
Outcome
In the present study, the outcomes of the study were the sexual function of the participants including men and women. Moreover, in the men, the subscales of sexual desire, orgasmic function, intercourse satisfaction, erectile function, and overall satisfaction were assessed. Also, in the women, the subscales of desire, arousal, lubrication, orgasm, pain, and sexual satisfaction were measured. The outcomes measured in before, and after intervention (week 0, week 8).
Statistical analysis
The effectiveness analysis was based on changes in questionnaire response scores from the beginning of treatment to the end of 8 weeks. The Kolmogorov-Smirnov test was used to investigate normal distribution. A p-value of less than 0.05 was used for statistical significance. Statistical analysis was performed by SPSS statistical package 16 (SPSS Inc., Chicago, IL, USA). Finally, statistical data analysis was done by Mann-Whitney, independent t-test, chi-square, Wilcoxon and paired t-test.

Findings
80 patients with diabetes participated and remained until the end of the study.
Demographic characteristics of patients
The mean±standard deviation age of the patients participating in the control group and the intervention group was 42.15±7.94 years and 42.63±5.78 years, respectively, which had no significant difference (p=0.780). In the control group, 65% and in the intervention group, 55% of the participants were men (p=0.361).
Comparison of laboratory findings
Since the level of hormones is effective in sexual function, it was necessary to prove the correct function of sex hormones and their normality for these patients, which in this study the levels of HbA1C, HDL, testosterone and prolactin were compared between the two groups before the intervention. According to the findings, there was no significant difference between the levels of HbA1C (p=0.150), HDL (p=0.809), testosterone (p=0.051) and prolactin (p=0.470) between the control and intervention groups before the intervention (Table 1).

Table 1. Comparison of laboratory findings of diabetic patients in the control group and the group receiving ginseng in the baseline


Comparison of men's sexual performance before and after the intervention between the control group and the group receiving ginseng
To evaluate the effectiveness of the intervention, the International Erectile Function Scale (IIEF) for men was used. According to the obtained results, the mean±standard deviation of the international scale of erectile function (IIEF) before the intervention in the control group and the group receiving ginseng was 28.08±5.93 and 30.73±8.15, respectively. There was no significant difference (p=0.199; Table 2).
The mean±standard deviation of the International Erectile Function Scale (IIEF) after the intervention in the control group and the group receiving ginseng was 27.81±6.02 and 44.95±7.64, respectively, which in the group receiving ginseng, it was significantly higher than control group (p<0.001; Table 2). It was also shown that all aspects of orgasmic function, sexual desire, erectile function, sexual satisfaction, and overall individual satisfaction in men improved significantly after the intervention compared to the control group (p<0.05; Table 2).

Table 2. Comparison of men's sexual function before the intervention in the control group and the group receiving ginseng


Examining the changes in sexual performance of men within and between groups
Paired t-test and Wilcoxon test were used to investigate the effect of ginseng on men's sexual performance and intra-group comparison. The results showed that in the control group, the changes made in none of the dimensions before and after the intervention were not significant (p<0.05). Nevertheless, the results showed that in the group receiving ginseng, except for the orgasmic performance, all other dimensions of sexual performance in men had a significant increase compared to before the intervention (p<0.05). Finally, the results showed a significant effect of ginseng consumption on changes in sexual performance over time compared to the control group (p<0.001; Table 3).

Table 3. Examining changes in male sexual performance within groups


Examining the changes in sexual performance of women within and between groups
To evaluate the impact of the intervention, the Women's Sexual Function Index (FSFI) was used for women. According to the obtained results, the mean±standard deviation of women's sexual function index (FSFI) before the intervention in the control group and the group receiving ginseng was 47.36±5.93 and 46.06±5.47, respectively, which there was no significant difference (p=0.525; Table 4).
The mean±standard deviation of women's sexual function index (FSFI) after the intervention in the control group and the group receiving ginseng was 21.47±8.41 and 17.66±5.63, respectively, which in the receiving group ginseng was significantly higher (p<0.001; Table 4). It was also shown that all aspects of sexual desire, psychological stimulation, moisture, orgasm, satisfaction, and sexual pain in women improved significantly after the intervention compared to the control group (p<0.05; Table 4).

Table 4. Comparison of women's sexual performance before and after the intervention between the control group and the group receiving ginseng


Examining the changes in sexual performance of women within groups
Paired t-test and Wilcoxon were used to investigate the effect of ginseng on women's sexual performance and intra-group comparison. The results showed that in the control group, the changes made in none of the dimensions before and after the intervention were significant (p<0.05). Nevertheless, the results showed that in the group receiving ginseng, all dimensions of sexual performance in women significantly increased compared to before the intervention (p<0.05). Finally, the results showed a significant effect of ginseng consumption on changes in women's sexual performance over time compared to the control group (p<0.001; Table 5).

Table 5. Examination of changes in sexual performance of women within groups


Discussion
The aim of this study was to investigate the effect of soft gelatin capsules of ginseng on sexual desire in patients with diabetes. Some studies investigated the effects of ginseng on indexes of diabetes mellitus and other metabolites. Naseri et al., in the systematic review and meta-analysis on prediabetes patients with type 2 diabetes mellitus, indicate that ginseng supplementation improves HR and TNF-α levels, HOMA-IR, TC and LDL-C significantly [12]. Moreover, in two studies on patients with type 2 diabetes, the results revealed that red ginseng extract improved high-density lipoprotein cholesterol (HDL-C), the levels of total cholesterol, fasting insulin (FINS), and serum glucose (GLU), significantly [13-15]. Also, in the study by Liu et al., according to the metabolomics analysis,101 potential biomarkers among which 94 metabolites had improvement [14].
Ginseng, a popular herbal medicine with adaptogenic and aphrodisiac properties, has been studied for its potential effects on sexual function. While some research show the positive effect of ginseng on libido and sexual performance, its effectiveness in diabetic patients has not yet been investigated. The results of the present study showed that ginseng improved the sexual function of men and its subscales including sexual desire, orgasmic function, intercourse satisfaction, erectile function, and overall satisfaction. Also, in the women, the sexual function and subscales of desire, arousal, lubrication, orgasm, pain, and sexual satisfaction were improved. The mechanism of action of ginseng herbal medicine on sexual performance involves a complex interaction of various physiological processes. Ginseng, especially panax ginseng, has been widely studied for its potential therapeutic effects on sexual dysfunction, including erectile dysfunction. Existing research showed that ginseng may have a positive effect on erectile dysfunction through various mechanisms; Ginsenosides, the medicinally active components of ginseng, act as inducers of NO synthesis in endothelial cells and surrounding nerves. This release of NO relaxes the smooth muscles and allows more blood to enter the cavernous bodies of the penis known as the corpus cavernosum, thus facilitating erection [23, 30, 31].
Farnia et al. have revealed in a study that ginseng treatment recovers the sexual side effects of methadone maintenance treatment. Moreover, sexual function improves significantly over time in the ginseng group compared to the placebo group [32]. Compared to our study, both studies show significant improvement in sexual performance with ginseng treatment compared to placebo, and both include male and female participants. Unlike our study, Farnia et al. study patients with OUD (opioid use disorder), while our study targeted diabetic patients. The duration of Farnia et al.'s study is four weeks, while our study was eight weeks. Farnia et al. include a smaller sample size (74 vs. 80). Consistent findings between these two studies show that ginseng has a wide range of uses in the treatment of sexual dysfunction in a variety of conditions. The longer duration and specific focus of our study on diabetes will add valuable insights and demonstrate the efficacy of ginseng over a longer period and in different patient populations.
In the present study, sexual function in women improved after intervention. In a meta-analysis study, Ghorbani & Mirghafourvand have investigated the effectiveness of panax ginseng on the sexual function of postmenopausal women. In this meta-analysis, they have included 531 women and have compared ginseng with a placebo. Ginseng does not show a statistically remarked impact on female sexual dysfunction in comparison to placebo [33]. Both studies evaluated the effect of ginseng on women's sexual performance using standard questionnaires. Both included placebo-controlled designs. Ghorbani & Mirghafourvand have conducted a study on postmenopausal women, while our study focused on diabetic patients. In Ghorbani & Mirghafourvand's study, ginseng does not show a statistically significant effect on women's sexual dysfunction compared to placebo, while in our study, ginseng consumption had a beneficial effect on women's sexual performance. Maybe, this difference was due to hormonal and pathological changes in postmenopausal women or a difference in sample size. In another study, Chung et al. have investigated the effect of Korean red ginseng on female sexual performance in a placebo-controlled clinical trial. 41 premenopausal women participate in this study by administering three ginseng capsules (1 g per capsule) or a placebo daily. The findings of this group shows that total FSFI scores insignificantly increased after Korean red ginseng (KRG) treatment and placebo treatment. KRG treatment significantly improves arousal, libido, overall satisfaction, and orgasm. However, there is no treatment effect compared to placebo. Finally, they conclude that oral administration of KRG extract enhances sexual performance in premenopausal women. However, there has been no statistically significant change in comparison to placebo [24]. This study, like our study, uses the standard FSFI questionnaire, and like our study, it is a double-blind clinical trial. Unlike this group, our findings showed that ginseng could significantly improve the sexual function of women, this difference can be attributed to the difference in the studied population, our study focused on diabetic people, while the other findings were performed on premenopausal women.
In the present study, sexual function in men improved after intervention. In De Andrade et al., the International Index of Erectile Function score after treatment is markedly higher in the ginseng group in comparison to before treatment. In the ginseng group, 66.6% report improvement in erection research data show that ginseng can be an effective alternative to invasive methods for the treatment of erectile dysfunction in men [34]. Compared to our study, both studies include placebo-controlled designs which shows significant improvement in sexual function. However, De Andrade et al. include a smaller sample size (60 vs. 80) as compared to our study. However, in the above study, only erectile dysfunction is investigated while in the present study, sexual dysfunction and other subscales were studied.
One of the limitations of the present study was the small number of patients. According to the results of the present study, the consumption of ginseng is recommended for diabetes patients with sexual dysfunction, if the results will be confirmed in similar studies. The adaptogenic and aphrodisiac properties of ginseng, along with its bioactive compounds such as ginsenosides, may play a key role in exerting these positive effects on sexual health. It is also recommended that in future studies, the components of ginseng be identified and the effects of the components be examined separately.

Conclusion
Ginseng intervention leads to a significant improvement in sexual function in male and female diabetic patients. Ginseng herbal medicine has potential benefits in increasing sexual performance in diabetic patients.

Acknowledgments: This article was derived thesis of Afshin Bagheri Fard in MD degree at Yasuj University of Medical Sciences. We gratefully acknowledge the Vice Chancellor for Research, Yasuj University of Medical Sciences for the support.
Ethical Permissions: This study is approved under the ethical approval code of IR.YUMS.REC.1402.120, and conducted based on the Declaration of Helsinki. Informed consent was obtained from the patients. Confidentiality of information, anonymity, and privacy of the patients were taken into account. Patients had the right to withdraw from the study if they wished. There was no physical or financial harm to the patients.
Conflicts of Interests: The authors declare that there is no conflict of interest.
Authors' Contribution: Mostafavi L (First Author), Main Author/Introduction Writer (25%); Bagheri Fard A (Second Author), Assistant Researcher/Methodologist/Discussion Writer (35%); Rahami Z (Third Author), Original Researcher/Discussion Writer/Introduction Writer (40%)
Funding/Support: This paper was financially supported by a grant from the vice chancellor of Research Affairs of Yasuj University of Medical Sciences (Grant number: 4010113).
Keywords:

References
1. Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: A scientific review. Diabetes Care. 2020;44(1):258-79. [Link] [DOI:10.2337/dci20-0053]
2. Unnikrishnan R, Misra A. Diabetes and COVID19: A bidirectional relationship. Nutr Diabetes. 2021;11(1):21. [Link] [DOI:10.1038/s41387-021-00163-2]
3. Eckel RH, Bornfeldt KE, Goldberg IJ. Cardiovascular disease in diabetes, beyond glucose. Cell Metab. 2021;33(8):1519-45. [Link] [DOI:10.1016/j.cmet.2021.07.001]
4. Turley RK. Overview of clinical complications of diabetes [Internet]. Columbus: Nationwide Children's Hospital; 2022 [cited 2022, January, 5]. Available from: https://www.nationwidechildrens.org/family-. resources-education/family-resources-library/overview-of-clinical-complications-of-diabetes. [Link]
5. Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, et al. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes Metab Res Rev. 2022;38(2):e3494. [Link] [DOI:10.1002/dmrr.3494]
6. Enzlin P, Rosen R, Wiegel M, Brown J, Wessells H, Gatcomb P, et al. Sexual dysfunction in women with type 1 diabetes: Long-term findings from the DCCT/EDIC study cohort. Diabetes Care. 2009;32(5):780-5. [Link] [DOI:10.2337/dc08-1164]
7. Elyasi F, Kashi Z, Tasfieh B, Bahar A, Khademloo M. Sexual dysfunction in women with type 2 diabetes mellitus. Iran J Med Sci. 2015;40(3):206-13. [Link]
8. Thomford NE, Senthebane DA, Rowe A, Munro D, Seele P, Maroyi A, et al. Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int J Mol Sci. 2018;19(6):1578. [Link] [DOI:10.3390/ijms19061578]
9. Hyun SH, Bhilare KD, In G, Park CK, Kim JH. Effects of panax ginseng and ginsenosides on oxidative stress and cardiovascular diseases: Pharmacological and therapeutic roles. J Ginseng Res. 2022;46(1):33-8. [Link] [DOI:10.1016/j.jgr.2021.07.007]
10. Kang Z, Zhonga Y, Wu T, Huang J, Zhao H, Liu D. Ginsenoside from ginseng: A promising treatment for inflammatory bowel disease. Pharmacol Rep. 2021;73(3):700-11. [Link] [DOI:10.1007/s43440-020-00213-z]
11. Zhang M, Niu H, Li Q, Jiao L, Li H, Wu W. Active compounds of panax ginseng in the improvement of alzheimer's disease and application of spatial metabolomics. Pharmaceuticals. 2024;17(1):38. [Link] [DOI:10.3390/ph17010038]
12. Naseri K, Saadati S, Sadeghi A, Asbaghi O, Ghaemi F, Zafarani F, et al. The efficacy of ginseng (panax) on human prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis. Nutrients. 2022;14(12):2401. [Link] [DOI:10.3390/nu14122401]
13. Yang Z, Wang D, Li Y, Zhou X, Liu T, Shi C, et al. Untargeted metabolomics analysis of the anti-diabetic effect of red ginseng extract in type 2 diabetes mellitus rats based on UHPLC-MS/MS. Biomed Pharmacother. 2022;146:112495. [Link] [DOI:10.1016/j.biopha.2021.112495]
14. Liu T, Wang D, Zhou X, Song J, Yang Z, Shi C, et al. Study on the mechanism of American ginseng extract for treating type 2 diabetes mellitus based on metabolomics. Front Pharmacol. 2022;13:960050. [Link] [DOI:10.3389/fphar.2022.960050]
15. Li MH, Jin MH, Hu RY, Tang S, Li KK, Gong XJ, et al. Exploring the mechanism of active components from ginseng to manage diabetes mellitus based on network pharmacology and molecular docking. Sci Rep. 2023;13(1):793. [Link] [DOI:10.1038/s41598-023-27540-4]
16. Karmazyn M, Gan XT. Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension. Mol Cell Biochem. 2021;476(1):333-47. [Link] [DOI:10.1007/s11010-020-03910-8]
17. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res. 2021;45(2):199-210. [Link] [DOI:10.1016/j.jgr.2020.02.004]
18. Hong H, Baatar D, Hwang SG. Anticancer activities of ginsenosides, the main active components of ginseng. Evid Based Complement Alternat Med. 2021;2021(1):8858006. [Link] [DOI:10.1155/2021/8858006]
19. Aghighi Alaghejonban G, Mokaberinejad R, Alizadeh K, Eslami R. Effectiveness of onion (allium cepa) on the improvement of sexual disorders in men: A review study. Complement Med J. 2024;13(4):28-43. [Persian] [Link] [DOI:10.61186/cmja.13.4.28]
20. Smith RG, Caswell D, Carriere A, Zielke B. Variation in the ginsenoside content of American ginseng, panax quinquefolius L., roots. Can J Bot. 1996;74(10):1616-20. [Link] [DOI:10.1139/b96-195]
21. Ghorbani Z, Mirghafourvand M, Charandabi SM, Javadzadeh Y. The effect of ginseng on sexual dysfunction in menopausal women: A double-blind, randomized, controlled trial. Complement Ther Med. 2019;45:57-64. [Link] [DOI:10.1016/j.ctim.2019.05.015]
22. Leung KW, Wong AS. Ginseng and male reproductive function. Spermatogenesis. 2013;3(3):e26391. [Link] [DOI:10.4161/spmg.26391]
23. De Andrade E, De Mesquita AA, De Almeida Claro J, De Andrade PM, Ortiz V, Paranhos M, et al. Study of the efficacy of Korean red ginseng in the treatment of erectile dysfunction. Asian J Androl. 2007;9(2):241-4. [Link] [DOI:10.1111/j.1745-7262.2007.00210.x]
24. Chung HS, Hwang I, Oh KJ, Lee MN, Park K. The effect of Korean red ginseng on sexual function in premenopausal women: Placebo‐controlled, double‐blind, crossover clinical trial. Evid Based Complement Alternat Med. 2015;2015(1):913158. [Link] [DOI:10.1155/2015/913158]
25. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-30. [Link] [DOI:10.1016/S0090-4295(97)00238-0]
26. Fakhri A, Morshedi H, Soleymanian A. Psychometric properties of Iranian version of male sexual function index. Jundishapur Sci Med J. 2013;12(6):655-63. [Persian] [Link]
27. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208. [Link] [DOI:10.1080/009262300278597]
28. Tan SY, Wong JL, Sim YJ, Wong SS, Elhassan SA, Tan SH, et al. Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr. 2019;13(1):364-72. [Link] [DOI:10.1016/j.dsx.2018.10.008]
29. Mohammadi Kh, Heydari M, Faghihzadeh S. The female sexual function index (FSFI): Validation of the Iranian version. PAYESH. 2008;7(3). [Persian] [Link]
30. Murphy LL, Lee TJ. Ginseng, sex behavior, and nitric oxide. Ann N Y Acad Sci. 2002;962(1):372-7. [Link] [DOI:10.1111/j.1749-6632.2002.tb04081.x]
31. Choi YD, Park CW, Jang J, Kim SH, Jeon HY, Kim WG, et al. Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: A multicenter, placebo-controlled, double-blind clinical study. Int J Impot Res. 2013;25(2):45-50. [Link] [DOI:10.1038/ijir.2012.45]
32. Farnia V, Alikhani M, Ebrahimi A, Golshani S, Bahmani DS, Brand S. Ginseng treatment improves the sexual side effects of methadone maintenance treatment. Psychiatry Res. 2019;276:142-50. [Link] [DOI:10.1016/j.psychres.2019.05.004]
33. Ghorbani Z, Mirghafourvand M. A meta-analysis of the efficacy of panax ginseng on menopausal women's sexual function. Int J Womens Health Reprod Sci. 2019;7(1):124-33. [Link] [DOI:10.15296/ijwhr.2019.20]